$REPL
Price history, market instrument context, member research, and related headlines in one place.
REPL key statistics
NasdaqGSUSD
52-week range
$1.5069%$16.33
Latest session $11.23–$11.86Replimune Group, Inc. (REPL) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $11.75, up $0.36 (3.16%) from the previous close of $11.39. It has traded between $11.23 and $11.86 in the latest session. Over the past year it has ranged from $1.50 to $16.33, leaving it in the upper half of its 52-week range (69%). Reported volume for the session was 1.6M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Replimune CFO Emily Hill sells $132,175 in stock for tax obligations — See source for full details.
Replimune Group stock may move 5.6% on earnings release — See source for full details.
Why is Replimune stock surging today? — See source for full details.
Replimune Group stock hits 52-week high at 13.92 USD — See source for full details.
Replimune in the spotlight: Earnings loom days after FDA approval — See source for full details.
Wedbush upgrades Replimune stock rating on FDA approval — See source for full details.
Why is Replimune stock volatile today? — See source for full details.
Replimune rebounds as positive AdCom vote prompts Cantor upgrade — See source for full details.
Wedbush upgrades Replimune stock rating on FDA panel support — See source for full details.
Loading $REPL research…